JP2020507351A - 酵母における植物性カンナビノイド及び植物性カンナビノイドアナログの生成のための方法及び細胞株 - Google Patents
酵母における植物性カンナビノイド及び植物性カンナビノイドアナログの生成のための方法及び細胞株 Download PDFInfo
- Publication number
- JP2020507351A JP2020507351A JP2019565595A JP2019565595A JP2020507351A JP 2020507351 A JP2020507351 A JP 2020507351A JP 2019565595 A JP2019565595 A JP 2019565595A JP 2019565595 A JP2019565595 A JP 2019565595A JP 2020507351 A JP2020507351 A JP 2020507351A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polynucleotide
- enzyme
- plant cannabinoid
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003557 cannabinoid Substances 0.000 title claims abstract description 193
- 229930003827 cannabinoid Natural products 0.000 title claims abstract description 191
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 94
- 238000000034 method Methods 0.000 title claims abstract description 92
- 238000004519 manufacturing process Methods 0.000 title claims description 65
- 229940065144 cannabinoids Drugs 0.000 title abstract description 57
- 241000196324 Embryophyta Species 0.000 claims abstract description 172
- IRMPFYJSHJGOPE-UHFFFAOYSA-N olivetol Chemical compound CCCCCC1=CC(O)=CC(O)=C1 IRMPFYJSHJGOPE-UHFFFAOYSA-N 0.000 claims abstract description 133
- 210000005253 yeast cell Anatomy 0.000 claims abstract description 92
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 74
- 108010030975 Polyketide Synthases Proteins 0.000 claims abstract description 62
- 102000005454 Dimethylallyltranstransferase Human genes 0.000 claims abstract description 61
- 108010006731 Dimethylallyltranstransferase Proteins 0.000 claims abstract description 61
- LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 claims abstract description 52
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 claims abstract description 52
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 45
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims abstract description 43
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims abstract description 43
- 235000009120 camo Nutrition 0.000 claims abstract description 43
- 235000005607 chanvre indien Nutrition 0.000 claims abstract description 43
- 239000011487 hemp Substances 0.000 claims abstract description 43
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 claims abstract description 38
- 230000001086 cytosolic effect Effects 0.000 claims abstract description 37
- 230000000694 effects Effects 0.000 claims abstract description 30
- SXFKFRRXJUJGSS-UHFFFAOYSA-N olivetolic acid Chemical compound CCCCCC1=CC(O)=CC(O)=C1C(O)=O SXFKFRRXJUJGSS-UHFFFAOYSA-N 0.000 claims abstract description 24
- 210000004027 cell Anatomy 0.000 claims abstract description 22
- FZOWKKHJBQFDPU-UHFFFAOYSA-N 2-methyl-5-pentylbenzene-1,3-diol Chemical compound CCCCCC1=CC(O)=C(C)C(O)=C1 FZOWKKHJBQFDPU-UHFFFAOYSA-N 0.000 claims abstract description 19
- GVVPGTZRZFNKDS-YFHOEESVSA-N Geranyl diphosphate Natural products CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 claims abstract description 10
- 241000187180 Streptomyces sp. Species 0.000 claims abstract description 8
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 5
- 108091033319 polynucleotide Proteins 0.000 claims description 154
- 239000002157 polynucleotide Substances 0.000 claims description 154
- 102000040430 polynucleotide Human genes 0.000 claims description 154
- 108090000623 proteins and genes Proteins 0.000 claims description 97
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 61
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 60
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 claims description 60
- 108091026890 Coding region Proteins 0.000 claims description 51
- 102000004169 proteins and genes Human genes 0.000 claims description 50
- 125000000539 amino acid group Chemical group 0.000 claims description 41
- 230000010354 integration Effects 0.000 claims description 41
- 239000000126 substance Substances 0.000 claims description 40
- 101100373202 Rattus norvegicus Cx3cl1 gene Proteins 0.000 claims description 39
- 239000002243 precursor Substances 0.000 claims description 39
- 102000004190 Enzymes Human genes 0.000 claims description 38
- 108090000790 Enzymes Proteins 0.000 claims description 38
- 230000014509 gene expression Effects 0.000 claims description 37
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 32
- 101150039067 maf-1 gene Proteins 0.000 claims description 29
- 241000894007 species Species 0.000 claims description 29
- 125000000217 alkyl group Chemical group 0.000 claims description 28
- 101150022636 MAFB gene Proteins 0.000 claims description 26
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 claims description 24
- 230000004048 modification Effects 0.000 claims description 24
- 238000012986 modification Methods 0.000 claims description 24
- 238000012239 gene modification Methods 0.000 claims description 22
- 230000005017 genetic modification Effects 0.000 claims description 22
- 235000013617 genetically modified food Nutrition 0.000 claims description 22
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 21
- 230000035772 mutation Effects 0.000 claims description 20
- 230000001965 increasing effect Effects 0.000 claims description 18
- 229930001119 polyketide Natural products 0.000 claims description 18
- 239000002773 nucleotide Substances 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 17
- 108010001814 phosphopantetheinyl transferase Proteins 0.000 claims description 17
- 102220177799 rs775915651 Human genes 0.000 claims description 17
- 150000003881 polyketide derivatives Chemical class 0.000 claims description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 102220518350 NAD-dependent protein deacetylase sirtuin-1_S659A_mutation Human genes 0.000 claims description 13
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 12
- 230000011987 methylation Effects 0.000 claims description 12
- 238000007069 methylation reaction Methods 0.000 claims description 12
- 102220101297 rs748101941 Human genes 0.000 claims description 12
- 101710095468 Cyclase Proteins 0.000 claims description 9
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 claims description 9
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 claims description 9
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 claims description 9
- -1 R2 is H Chemical group 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 102220033048 rs62645931 Human genes 0.000 claims description 8
- 102220085639 rs748675400 Human genes 0.000 claims description 8
- 241000351920 Aspergillus nidulans Species 0.000 claims description 7
- 230000001131 transforming effect Effects 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 229930182558 Sterol Natural products 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 6
- 150000003432 sterols Chemical class 0.000 claims description 6
- 235000003702 sterols Nutrition 0.000 claims description 6
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 claims description 5
- 239000012190 activator Substances 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 5
- 241001138501 Salmonella enterica Species 0.000 claims description 4
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims description 3
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 claims description 3
- 241000228245 Aspergillus niger Species 0.000 claims description 3
- 230000000415 inactivating effect Effects 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 23
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 abstract description 14
- 230000015556 catabolic process Effects 0.000 abstract description 10
- 230000002438 mitochondrial effect Effects 0.000 abstract description 7
- 230000013823 prenylation Effects 0.000 abstract description 5
- 102000004357 Transferases Human genes 0.000 abstract description 2
- 108090000992 Transferases Proteins 0.000 abstract description 2
- 241000006667 Palicarinus niger Species 0.000 abstract 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 89
- 238000006243 chemical reaction Methods 0.000 description 49
- 239000013612 plasmid Substances 0.000 description 41
- 235000018102 proteins Nutrition 0.000 description 35
- 108020004414 DNA Proteins 0.000 description 27
- 239000002253 acid Substances 0.000 description 20
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 19
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 19
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 19
- 229930182830 galactose Natural products 0.000 description 18
- 108091033409 CRISPR Proteins 0.000 description 17
- 101100313266 Mus musculus Tead1 gene Proteins 0.000 description 17
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 16
- 239000002609 medium Substances 0.000 description 14
- 239000012528 membrane Substances 0.000 description 14
- 230000009261 transgenic effect Effects 0.000 description 14
- OEXFMSFODMQEPE-HDRQGHTBSA-N hexanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 OEXFMSFODMQEPE-HDRQGHTBSA-N 0.000 description 13
- 238000006467 substitution reaction Methods 0.000 description 13
- 230000006801 homologous recombination Effects 0.000 description 12
- 238000002744 homologous recombination Methods 0.000 description 12
- 230000009466 transformation Effects 0.000 description 12
- 238000013459 approach Methods 0.000 description 11
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 10
- 229960004242 dronabinol Drugs 0.000 description 10
- 239000002207 metabolite Substances 0.000 description 10
- 108020005004 Guide RNA Proteins 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 9
- 238000010586 diagram Methods 0.000 description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000010354 CRISPR gene editing Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 101100129232 Danio rerio mafaa gene Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 101150026303 HEX1 gene Proteins 0.000 description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 235000013311 vegetables Nutrition 0.000 description 6
- 101100268665 Caenorhabditis elegans acc-1 gene Proteins 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 229950011318 cannabidiol Drugs 0.000 description 5
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical group C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 5
- 230000005782 double-strand break Effects 0.000 description 5
- 239000013613 expression plasmid Substances 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229930003658 monoterpene Natural products 0.000 description 5
- 150000002773 monoterpene derivatives Chemical class 0.000 description 5
- 235000002577 monoterpenes Nutrition 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 4
- 244000198134 Agave sisalana Species 0.000 description 4
- 235000011624 Agave sisalana Nutrition 0.000 description 4
- UVOLYTDXHDXWJU-NRFANRHFSA-N Cannabichromene Natural products C1=C[C@](C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-NRFANRHFSA-N 0.000 description 4
- UVOLYTDXHDXWJU-UHFFFAOYSA-N Cannabichromene Chemical compound C1=CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-UHFFFAOYSA-N 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 4
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 4
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 238000006114 decarboxylation reaction Methods 0.000 description 4
- 230000037353 metabolic pathway Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 150000003505 terpenes Chemical class 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 101100321442 Arabidopsis thaliana ZHD1 gene Proteins 0.000 description 3
- 241000168726 Dictyostelium discoideum Species 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 3
- 244000253911 Saccharomyces fragilis Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 125000000830 polyketide group Chemical group 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 229940035893 uracil Drugs 0.000 description 3
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000008697 Cannabis sativa Nutrition 0.000 description 2
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 2
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 108010039731 Fatty Acid Synthases Proteins 0.000 description 2
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 2
- 241001138401 Kluyveromyces lactis Species 0.000 description 2
- 229910009891 LiAc Inorganic materials 0.000 description 2
- 102000019337 Prenyltransferases Human genes 0.000 description 2
- 108050006837 Prenyltransferases Proteins 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- 241000221523 Rhodotorula toruloides Species 0.000 description 2
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 2
- 241000235015 Yarrowia lipolytica Species 0.000 description 2
- KNGQILZSJUUYIK-VIFPVBQESA-N [(2R)-4-hydroxy-3,3-dimethyl-1-oxo-1-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butan-2-yl] dihydrogen phosphate Chemical group OCC(C)(C)[C@@H](OP(O)(O)=O)C(=O)NCCC(=O)NCCS KNGQILZSJUUYIK-VIFPVBQESA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- IGHTZQUIFGUJTG-UHFFFAOYSA-N cannabicyclol Chemical compound O1C2=CC(CCCCC)=CC(O)=C2C2C(C)(C)C3C2C1(C)CC3 IGHTZQUIFGUJTG-UHFFFAOYSA-N 0.000 description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 238000010362 genome editing Methods 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012269 metabolic engineering Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 101150079312 pgk1 gene Proteins 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IXJXRDCCQRZSDV-GCKMJXCFSA-N (6ar,9r,10as)-6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6h-1,9-epoxybenzo[c]chromene Chemical compound C1C[C@@H](C(O2)(C)C)[C@@H]3C[C@]1(C)OC1=C3C2=CC(CCCCC)=C1 IXJXRDCCQRZSDV-GCKMJXCFSA-N 0.000 description 1
- VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 1
- GADSJKKDLMALGL-UHFFFAOYSA-N 2-propylbenzoic acid Chemical compound CCCC1=CC=CC=C1C(O)=O GADSJKKDLMALGL-UHFFFAOYSA-N 0.000 description 1
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- CUXFFBBWEJOYAI-UHFFFAOYSA-N 4-methyl-5-pentylbenzene-1,3-diol Chemical compound CCCCCC1=CC(O)=CC(O)=C1C CUXFFBBWEJOYAI-UHFFFAOYSA-N 0.000 description 1
- 101710146995 Acyl carrier protein Proteins 0.000 description 1
- 102100039075 Aldehyde dehydrogenase family 1 member A3 Human genes 0.000 description 1
- 101710192173 Aldehyde dehydrogenase family 1 member A3 Proteins 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 102000011802 Beta-ketoacyl synthases Human genes 0.000 description 1
- 108050002233 Beta-ketoacyl synthases Proteins 0.000 description 1
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 1
- 108010075293 Cannabidiolic acid synthase Proteins 0.000 description 1
- SEEZIOZEUUMJME-VBKFSLOCSA-N Cannabigerolic acid Natural products CCCCCC1=CC(O)=C(C\C=C(\C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-VBKFSLOCSA-N 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 101000712615 Cannabis sativa Tetrahydrocannabinolic acid synthase Proteins 0.000 description 1
- UCONUSSAWGCZMV-HZPDHXFCSA-N Delta(9)-tetrahydrocannabinolic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C(O)=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-N 0.000 description 1
- YOVRGSHRZRJTLZ-UHFFFAOYSA-N Delta9-THCA Natural products C1=C(C(O)=O)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 YOVRGSHRZRJTLZ-UHFFFAOYSA-N 0.000 description 1
- XXGMIHXASFDFSM-UHFFFAOYSA-N Delta9-tetrahydrocannabinol Natural products CCCCCc1cc2OC(C)(C)C3CCC(=CC3c2c(O)c1O)C XXGMIHXASFDFSM-UHFFFAOYSA-N 0.000 description 1
- 241000238713 Dermatophagoides farinae Species 0.000 description 1
- ORKZJYDOERTGKY-UHFFFAOYSA-N Dihydrocannabichromen Natural products C1CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 ORKZJYDOERTGKY-UHFFFAOYSA-N 0.000 description 1
- 241000178290 Geotrichum fermentans Species 0.000 description 1
- 102000013404 Geranyltranstransferase Human genes 0.000 description 1
- 108010026318 Geranyltranstransferase Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 102100027490 H2.0-like homeobox protein Human genes 0.000 description 1
- 241000059563 Hemicrepidius niger Species 0.000 description 1
- 101001081101 Homo sapiens H2.0-like homeobox protein Proteins 0.000 description 1
- 101000942967 Homo sapiens Leukemia inhibitory factor Proteins 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 description 1
- 102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
- 241001149698 Lipomyces Species 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 101001014220 Monascus pilosus Dehydrogenase mokE Proteins 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 101000573542 Penicillium citrinum Compactin nonaketide synthase, enoyl reductase component Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 101100281395 Streptomyces cinnamonensis fnq26 gene Proteins 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 101100391513 Streptomyces sp. (strain KO-3988) fur7 gene Proteins 0.000 description 1
- 241000345373 Streptomyces sp. CL190 Species 0.000 description 1
- 101150001810 TEAD1 gene Proteins 0.000 description 1
- 101150074253 TEF1 gene Proteins 0.000 description 1
- 241001634922 Tausonia pullulans Species 0.000 description 1
- UCONUSSAWGCZMV-UHFFFAOYSA-N Tetrahydro-cannabinol-carbonsaeure Natural products O1C(C)(C)C2CCC(C)=CC2C2=C1C=C(CCCCC)C(C(O)=O)=C2O UCONUSSAWGCZMV-UHFFFAOYSA-N 0.000 description 1
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 1
- 108010089879 Type I Fatty Acid Synthase Proteins 0.000 description 1
- 101150012828 UPC2 gene Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- MLXFAJLGELDQJX-DJVIHCHSSA-N [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3R)-4-[[3-(2-butylsulfanylethylamino)-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl] hydrogen phosphate Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MLXFAJLGELDQJX-DJVIHCHSSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 108060000514 aromatic prenyltransferase Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 102220366780 c.4901A>C Human genes 0.000 description 1
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 1
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 1
- SEEZIOZEUUMJME-FOWTUZBSSA-N cannabigerolic acid Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-FOWTUZBSSA-N 0.000 description 1
- SEEZIOZEUUMJME-UHFFFAOYSA-N cannabinerolic acid Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-UHFFFAOYSA-N 0.000 description 1
- 125000001721 carboxyacetyl group Chemical group 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 101150066777 coq5 gene Proteins 0.000 description 1
- JVOHLEIRDMVLHS-UHFFFAOYSA-N ctk8i6127 Chemical compound C1=2C(O)=C(C(O)=O)C(CCCCC)=CC=2OC2(C)CCC3C(C)(C)C1C23 JVOHLEIRDMVLHS-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 1
- 230000009109 downstream regulation Effects 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- IPFXNYPSBSIFOB-UHFFFAOYSA-N isopentyl pyrophosphate Chemical compound CC(C)CCO[P@](O)(=O)OP(O)(O)=O IPFXNYPSBSIFOB-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- 230000006372 lipid accumulation Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012577 media supplement Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- RXUATCUKICAIOA-ZMHDXICWSA-N pentanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RXUATCUKICAIOA-ZMHDXICWSA-N 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000029305 taxis Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
- C07C39/08—Dihydroxy benzenes; Alkylated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
- C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1288—Transferases for other substituted phosphate groups (2.7.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01001—Alcohol dehydrogenase (1.1.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01041—Phosphoglycerol geranylgeranyltransferase (2.5.1.41)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/08—Transferases for other substituted phosphate groups (2.7.8)
- C12Y207/08007—Holo-[acyl-carrier-protein] synthase (2.7.8.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
- C12Y602/01—Acid-Thiol Ligases (6.2.1)
- C12Y602/01001—Acetate-CoA ligase (6.2.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762460526P | 2017-02-17 | 2017-02-17 | |
| US62/460,526 | 2017-02-17 | ||
| PCT/CA2018/050189 WO2018148848A1 (en) | 2017-02-17 | 2018-02-19 | Method and cell line for production of phytocannabinoids and phytocannabinoid analogues in yeast |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2020507351A true JP2020507351A (ja) | 2020-03-12 |
Family
ID=63169138
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565595A Pending JP2020507351A (ja) | 2017-02-17 | 2018-02-19 | 酵母における植物性カンナビノイド及び植物性カンナビノイドアナログの生成のための方法及び細胞株 |
| JP2019565596A Active JP7162018B6 (ja) | 2017-02-17 | 2018-02-19 | 酵母におけるポリケチドの生成のための方法及び細胞株 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565596A Active JP7162018B6 (ja) | 2017-02-17 | 2018-02-19 | 酵母におけるポリケチドの生成のための方法及び細胞株 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11078502B2 (https=) |
| EP (2) | EP3583222A4 (https=) |
| JP (2) | JP2020507351A (https=) |
| KR (2) | KR20200004784A (https=) |
| CN (2) | CN110651047B (https=) |
| AU (2) | AU2018220470B2 (https=) |
| CA (2) | CA3054423A1 (https=) |
| IL (2) | IL268725B2 (https=) |
| MX (2) | MX2019009708A (https=) |
| SG (2) | SG11201907504PA (https=) |
| WO (2) | WO2018148848A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115698272A (zh) * | 2020-04-08 | 2023-02-03 | 哥本哈根大学 | 二磷酸香叶酯衍生的化合物的产生 |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110914416B (zh) | 2017-04-27 | 2023-07-21 | 加州大学董事会 | 产生大麻素和大麻素衍生物的微生物和方法 |
| AU2018346434A1 (en) * | 2017-10-05 | 2020-05-14 | Intrexon Corporation | Microorganisms and methods for the fermentation of cannabinoids |
| WO2019190945A1 (en) * | 2018-03-29 | 2019-10-03 | William Marsh Rice University | Biosynthesis of olivetolic acid |
| AU2019262112A1 (en) | 2018-04-30 | 2020-11-19 | Algae-C Inc. | Engineered microorganism for the production of cannabinoid biosynthetic pathway products |
| WO2020060948A1 (en) | 2018-09-17 | 2020-03-26 | Levadura Biotechnology, Inc. | Production of cannabinoids in yeast using a fatty acid feedstock |
| IL326299A (en) * | 2018-10-31 | 2026-04-01 | Baymedica Inc | Cannabinoid analogs and methods for their preparation |
| CN113227353A (zh) * | 2018-11-14 | 2021-08-06 | 马努斯生物合成股份有限公司 | 用于产生大麻素的微生物细胞及方法 |
| MY205459A (en) * | 2018-12-06 | 2024-10-22 | Cytomx Therapeutics Inc | Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof |
| US20220127649A1 (en) * | 2019-01-30 | 2022-04-28 | Genomatica, Inc. | Engineered cells for improved production of cannabinoids |
| EP3917642A4 (en) | 2019-01-30 | 2023-04-05 | Genomatica, Inc. | RECOVERY, DECARBOXYLATION AND PURIFICATION OF CANNABINOIDS FROM GMO CULTURES |
| CA3130763A1 (en) | 2019-02-25 | 2020-09-03 | Ginkgo Bioworks, Inc. | Biosynthesis of cannabinoids and cannabinoid precursors |
| US20220186267A1 (en) * | 2019-03-27 | 2022-06-16 | Rynetech Bio, Inc. | Biosynthetic Cannabidiol Production In Engineered Microorganisms |
| SG11202112690YA (en) * | 2019-05-22 | 2021-12-30 | Hyasynth Biologicals Inc | Methods and cells for production of phytocannabinoids and phytocannabinoid precursors |
| ES3037766T3 (en) | 2019-06-11 | 2025-10-07 | Symrise Ag | Synthesis and purification of cannabigerol and its application |
| CA3151799A1 (en) * | 2019-08-18 | 2021-02-25 | Ginkgo Bioworks, Inc. | Biosynthesis of cannabinoids and cannabinoid precursors |
| EP4025705A4 (en) * | 2019-09-06 | 2024-01-17 | Genomatica, Inc. | PRENYL TRANSFERASE VARIANTS AND METHOD FOR PRODUCING PRENYLATED AROMATIC COMPOUNDS |
| CN120555521A (zh) * | 2019-10-01 | 2025-08-29 | 杭州恩和生物科技有限公司 | 用于大麻素合成的酶和制备大麻素的方法 |
| US20240084337A1 (en) * | 2019-10-11 | 2024-03-14 | National University Of Singapore | Biosynthesis of cannabinoid precursors using novel aromatic prenyl transferases |
| KR20220079578A (ko) | 2019-10-11 | 2022-06-13 | 내셔널 유니버시티 오브 싱가포르 | 신규 칸나비노이드 신타아제를 사용한 칸나비게롤산으로부터 칸나비노이드의 생합성 |
| MX2022008463A (es) | 2020-01-10 | 2022-10-18 | Univ California | Plataforma biosintética para la producción de ácido olivetólico y análogos del ácido olivetólico. |
| US20250346871A1 (en) * | 2020-03-06 | 2025-11-13 | Cellibre, Inc. | Prenyltransferases and methods of making and use thereof |
| EP4126916A2 (en) | 2020-03-27 | 2023-02-08 | Willow Biosciences Inc. | Compositions and methods for recombinant biosynthesis of cannabinoids |
| EP3901256A1 (en) * | 2020-04-21 | 2021-10-27 | Synbionik GmbH | Optimized production of cbga from olivetol acid and geranyl pyrophosphate via synnphb |
| CA3175683A1 (en) | 2020-04-29 | 2021-11-04 | Xueyang FENG | Compositions and methods for enhancing recombinant biosynthesis of cannabinoids |
| WO2021225952A1 (en) * | 2020-05-08 | 2021-11-11 | Lygos, Inc. | Large scale production of olivetol, olivetolic acid and other alkyl resorcinols by fermentation |
| EP4176054A1 (en) * | 2020-07-03 | 2023-05-10 | Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. -Hans-Knöll-Institut- (HKI) | Method for producing olivetolic acid in an amoebozoa host species |
| KR20230042073A (ko) * | 2020-07-24 | 2023-03-27 | 히야신스 바이오로지컬스 아이엔씨. | 치환된 칸나비노이드 및 전구체를 제조하기 위해 변형 효소를 이용하는 방법 및 이를 함유하는 세포 |
| CN111979134B (zh) | 2020-08-28 | 2022-02-15 | 江南大学 | 一种合成胭脂红酸的重组酿酒酵母的构建及其应用 |
| CN112042677B (zh) * | 2020-09-21 | 2021-09-14 | 中国农业科学院麻类研究所 | 一种大麻叶提取物及其制备方法、用途 |
| US11427840B2 (en) | 2020-11-20 | 2022-08-30 | Hyasynth Biologicals Inc. | Olivetolic acid cyclase variants with improved activity for use in production of phytocannabinoids |
| CA3199891A1 (en) * | 2020-11-24 | 2022-06-02 | Ruth Gallily | Cannabinoid derivatives and their use for the treatment of inflammation and/or pain and/or obesity |
| US20240026314A1 (en) * | 2020-11-25 | 2024-01-25 | Steven Rothstein | Polypeptides for use in the synthesis of bioactive phenolic compounds |
| WO2022125960A1 (en) | 2020-12-11 | 2022-06-16 | Willow Biosciences, Inc. | Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors |
| EP4347800A1 (en) | 2021-05-26 | 2024-04-10 | Invizyne Technologies, Inc. | Prenyltransferase variants with increased thermostability |
| WO2023010083A2 (en) | 2021-07-30 | 2023-02-02 | Willow Biosciences, Inc. | Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids |
| CA3227236A1 (en) | 2021-08-19 | 2023-02-23 | Trish Choudhary | Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids |
| CN113881584B (zh) * | 2021-09-16 | 2023-06-27 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 一株经航天育种技术选育的酿酒酵母及其突变位点应用 |
| WO2023056350A1 (en) * | 2021-09-29 | 2023-04-06 | Ginkgo Bioworks, Inc. | Biosynthesis of cannabinoids and cannabinoid precursors |
| WO2023069921A1 (en) | 2021-10-19 | 2023-04-27 | Epimeron Usa, Inc. | Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids |
| CN114621982B (zh) * | 2022-03-16 | 2023-11-07 | 嘉兴欣贝莱生物科技有限公司 | 香叶基二磷酸酯的生物合成方法及其在制备大麻类化合物中的应用 |
| CN116024111B (zh) * | 2022-12-03 | 2025-09-05 | 中国科学院深圳先进技术研究院 | 一种产大麻萜酚的微生物细胞及其构建方法与应用 |
| CN119685467A (zh) * | 2023-12-01 | 2025-03-25 | 上海市东方医院(同济大学附属东方医院) | 诊断和治疗阿尔茨海默病的医药制剂 |
| CN119753053A (zh) * | 2025-03-07 | 2025-04-04 | 中国农业科学院植物保护研究所 | 磷酸泛酰巯基乙胺基转移酶3x32、其编码基因、含有该基因的重组载体和重组菌的应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE455785T1 (de) | 2000-11-02 | 2010-02-15 | Ajinomoto Kk | Neue pyrazolderivate und diese enthaltende mittel gegen diabetes |
| US7238514B2 (en) | 2001-01-05 | 2007-07-03 | William Marsh Rice University | Diterpene-producing unicellular organism |
| EP1338608A3 (en) * | 2001-12-20 | 2004-05-06 | Cellzome Ag | Protein complexes and methods for their use |
| AU2002367554A1 (en) | 2001-12-20 | 2003-09-09 | Cellzome Ag | Protein complexes and methods for their use |
| US7186519B2 (en) | 2002-11-13 | 2007-03-06 | Trustees Of Dartmouth College | Method for detecting intracellular cholesterol |
| WO2006060839A2 (en) | 2004-12-10 | 2006-06-15 | Universität Für Bodenkultur Wien | Method for identifying ppt inhibitors |
| US7361483B2 (en) | 2005-01-28 | 2008-04-22 | The Salk Institute For Biological Studies | Aromatic prenyltransferases, nucleic acids encoding same and uses therefor |
| US20080233628A1 (en) * | 2006-09-14 | 2008-09-25 | The Salk Institute For Biological Studies | Incorporation of type III polyketide synthases into multidomain proteins of the type I and III polyketide synthase and fatty acid synthase families |
| CA2770774C (en) | 2009-08-12 | 2020-07-14 | National Research Council Of Canada | Aromatic prenyltransferase from cannabis |
| WO2011127569A1 (en) | 2010-04-14 | 2011-10-20 | Voiceage Corporation | Flexible and scalable combined innovation codebook for use in celp coder and decoder |
| CA3130705A1 (en) | 2010-04-15 | 2011-10-20 | National Research Council Of Canada | Genes and proteins for aromatic polyketide synthesis |
| EP2601292B1 (en) | 2010-08-06 | 2018-04-18 | Biopetrolia AB | Methods and products for production of wax esters |
| CN103562398A (zh) | 2011-03-22 | 2014-02-05 | Opx生物工艺学公司 | 化学产品的微生物生产以及相关的组合物、方法和系统 |
| WO2013006853A1 (en) | 2011-07-07 | 2013-01-10 | Cidra Corporate Services Inc. | Spectroscopic analysis of oil sands ore face for real time ore blend management |
| AU2012283708B2 (en) * | 2011-07-13 | 2017-02-23 | National Research Council Of Canada | Genes and proteins for alkanoyl-CoA synthesis |
| BR112014010448A2 (pt) * | 2011-11-02 | 2017-04-18 | Genomatica Inc | microorganismos e métodos para a produção de caprolactona |
| US9670494B2 (en) | 2012-01-06 | 2017-06-06 | Firmenich Sa | Genetically engineered yeast cells |
| WO2014018982A1 (en) * | 2012-07-27 | 2014-01-30 | The Regents Of The University Of California | Systems and methods for enhancing gene expression |
| WO2014134281A1 (en) | 2013-02-28 | 2014-09-04 | Full Spectrum Laboratories Limited | Biosynthesis of cannabinoids |
| EP3008178A1 (en) | 2013-06-14 | 2016-04-20 | Technical University of Denmark | Microbial production of 3-hydroxypropionic acid |
| WO2014207113A1 (en) | 2013-06-26 | 2014-12-31 | Abengoa Bioenergia Nuevas Tecnologias S.A. | Yeasts engineered for the production of valuable chemicals from sugars |
| US20160230200A1 (en) | 2013-09-05 | 2016-08-11 | Danmarks Tekniske Universitet | Microorganisms for efficient production of melatonin and related compounds |
| US9822384B2 (en) | 2014-07-14 | 2017-11-21 | Librede Inc. | Production of cannabinoids in yeast |
| US9394510B2 (en) | 2014-08-25 | 2016-07-19 | Full Spectrum Laboratories Limited | Apparatus and methods for the simultaneous production of compounds |
| DK3277827T3 (da) | 2015-04-02 | 2021-06-14 | Biopetrolia Ab | Svampeceller og fremgangsmåder til fremstilling af produkter afledt af meget langkædede fedtsyrer |
| WO2017139496A1 (en) | 2016-02-09 | 2017-08-17 | Cevolva Biotech, Inc. | Microbial engineering for the production of cannabinoids and cannabinoid precursors |
| EP3430151A4 (en) * | 2016-03-16 | 2020-09-02 | William Marsh Rice University | MICROBIAL SYNTHESIS OF ISOPRENOID, ISOPRENOID AND DERIVATIVE PRECURSORS INCLUDING PRENYLATED AROMATIC COMPOUNDS |
| CN110914416B (zh) | 2017-04-27 | 2023-07-21 | 加州大学董事会 | 产生大麻素和大麻素衍生物的微生物和方法 |
-
2018
- 2018-02-19 EP EP18754525.6A patent/EP3583222A4/en not_active Withdrawn
- 2018-02-19 US US16/486,618 patent/US11078502B2/en active Active
- 2018-02-19 KR KR1020197027008A patent/KR20200004784A/ko not_active Withdrawn
- 2018-02-19 US US16/486,610 patent/US11312979B2/en active Active
- 2018-02-19 SG SG11201907504PA patent/SG11201907504PA/en unknown
- 2018-02-19 JP JP2019565595A patent/JP2020507351A/ja active Pending
- 2018-02-19 CA CA3054423A patent/CA3054423A1/en active Pending
- 2018-02-19 EP EP18754640.3A patent/EP3583217A4/en not_active Withdrawn
- 2018-02-19 WO PCT/CA2018/050189 patent/WO2018148848A1/en not_active Ceased
- 2018-02-19 AU AU2018220470A patent/AU2018220470B2/en active Active
- 2018-02-19 AU AU2018220469A patent/AU2018220469B2/en active Active
- 2018-02-19 CA CA3054152A patent/CA3054152A1/en active Pending
- 2018-02-19 IL IL268725A patent/IL268725B2/en unknown
- 2018-02-19 CN CN201880025281.2A patent/CN110651047B/zh not_active Expired - Fee Related
- 2018-02-19 WO PCT/CA2018/050190 patent/WO2018148849A1/en not_active Ceased
- 2018-02-19 CN CN201880025692.1A patent/CN110637088B/zh not_active Expired - Fee Related
- 2018-02-19 SG SG11201907469YA patent/SG11201907469YA/en unknown
- 2018-02-19 JP JP2019565596A patent/JP7162018B6/ja active Active
- 2018-02-19 IL IL268723A patent/IL268723B2/en unknown
- 2018-02-19 MX MX2019009708A patent/MX2019009708A/es unknown
- 2018-02-19 MX MX2019009712A patent/MX2019009712A/es unknown
- 2018-02-19 KR KR1020197027012A patent/KR102589523B1/ko active Active
-
2020
- 2020-03-24 US US16/828,696 patent/US10975395B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115698272A (zh) * | 2020-04-08 | 2023-02-03 | 哥本哈根大学 | 二磷酸香叶酯衍生的化合物的产生 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020507351A (ja) | 酵母における植物性カンナビノイド及び植物性カンナビノイドアナログの生成のための方法及び細胞株 | |
| US11555211B2 (en) | Recombinant production systems for prenylated polyketides of the cannabinoid family | |
| JP7617858B2 (ja) | 植物性カンナビノイド及び植物性カンナビノイド前駆体の産生のための方法及び細胞 | |
| Schwartz et al. | Standardized markerless gene integration for pathway engineering in Yarrowia lipolytica | |
| US20230215512A1 (en) | Systems and Methods for Identifying and Expressing Gene Clusters | |
| US9663768B2 (en) | Precursor-directed biosynthesis of 5-hydroxytryptophan | |
| Shi et al. | Temperature influences β-carotene production in recombinant Saccharomyces cerevisiae expressing carotenogenic genes from Phaffia rhodozyma | |
| AU2008219996B2 (en) | Transformed strains originated from multidrug efflux protein defective strains and a method for microbial conversion using them | |
| WO2021042057A1 (en) | Systems and methods for preparing cannabinoids and derivatives | |
| CN112513263A (zh) | 产生折叶苔醇化合物的方法 | |
| US20210403959A1 (en) | Use of type i and type ii polyketide synthases for the production of cannabinoids and cannabinoid analogs | |
| US10006060B2 (en) | Selectivity of the production of vanilloids in a recombinant unicellular host | |
| JP7431733B2 (ja) | チトクロムp450モノオキシゲナーゼが触媒するセスキテルペンの酸化 | |
| CN116096857B (zh) | 由油棕空果串木质素生物合成商品化学品 | |
| US20240117388A1 (en) | Acyl activating enzymes for preparation of cannabinoids | |
| KR20240041434A (ko) | 효모에서 폴리케티드를 제조하기 위한 방법 | |
| JP2024538156A (ja) | カンナビノイド生合成のための最適化された生合成経路 | |
| Xiang | Investigation on the biosynthesis of polyketides in two Penicillium strains | |
| HK40111454A (zh) | 用於鉴定和表达基因簇的系统和方法 | |
| HK40011835A (en) | Systems and methods for identifying and expressing gene clusters | |
| HK40011835B (en) | Systems and methods for identifying and expressing gene clusters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191017 |